Back to results
CompletedPhase 2

Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease

NCT01018875

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Site Reference ID/Investigator# 22687

Kazan', Russia

+20 additional locations

View on ClinicalTrials.gov
Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease — TrialFind